EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders

Franz Felix Konen, Nora Möhn, Torsten Witte, Matthias Schefzyk, Miriam Wiestler, Svjetlana Lovric, Karsten Hufendiek, Konstantin Fritz Jendretzky, Stefan Gingele, Philipp Schwenkenbecher, Kurt-Wolfram Sühs, Manuel A Friese und 7 weitere

Autoimmunity Reviews · 2025

DOI: 10.1016/j.autrev.2025.103754 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Autoimmunity Reviews, 2025. Verfasst von Franz Felix Konen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hannover Medical School, 30625 Hannover, Germany. Electronic address: konen.felix@mh-hannover.de. Hauptthemen laut MEDLINE: Multiple Sclerosis, Autoimmune Diseases, Protein Kinases, Protein Kinase Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A wide variety of immunomodulatory therapies are already available for the treatment of multiple sclerosis (MS). Through fundamental insights from basic research with a gain of knowledge in the pathological processes underlying MS, the exploration of additional medical compounds within clinical trials has been ignited. Emerging novel medications with innovative mechanisms of action are being introduced. Those mechanisms of action include a broad therapeutic spectrum of substances targeting various protein kinases, some of which could also be used for the treatment of other autoimmune-mediated diseases. The advancement of new compounds could therefore enable a more personalized approach in treating MS, taking into consideration patients' co-existing autoimmune-mediated diseases. In this review, we discuss potential compounds targeting protein kinases, currently under investigation in clinical trials for various autoimmune diseases that could become viable treatment options for MS and comorbid autoimmune conditions in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisAutoimmune DiseasesProtein KinasesProtein Kinase InhibitorsHumansAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

Autoimmune disordersBTK inhibitorsJAK inhibitorsMultiple sclerosisNeuroinflammatory disordersProtein kinases

Substanzen

Protein KinasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Neurology, Hannover Medical School, 30625 Hannover, Germany. Electronic address: konen.felix@mh-hannover.de.
  • Department of Neurology, Hannover Medical School, 30625 Hannover, Germany. Electronic address: moehn.nora@mh-hannover.de.
  • Department of Rheumatology and Clinical Immunology, Hannover Medical School, 30625 Hannover, Germany. Electronic address: witte.torsten@mh-hannover.de.
  • Department of Dermatology, Allergology und Venerology, Hannover Medical School, 30625 Hannover, Germany. Electronic address: schefzyk.matthias@mh-hannover.de.
  • Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. Electronic address: wiestler.miriam@mh-hannover.de.
  • Department of Nephrology and Hypertension, Hannover Medical School, 30625 Hannover, Germany. Electronic address: lovric.svjetlana@mh-hannover.de.

Zitieren

APA

Konen, F. F., Möhn, N., Witte, T., Schefzyk, M., Wiestler, M., Lovric, S., Hufendiek, K., Jendretzky, K. F., Gingele, S., Schwenkenbecher, P., Sühs, K. W., Friese, M. A., Klotz, L., Pul, R., Pawlitzki, M., Hagin, D., Kleinschnitz, C., Meuth, S. G., & Skripuletz, T. (2025). Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2025.103754

Vancouver

Konen FF, Möhn N, Witte T, Schefzyk M, Wiestler M, Lovric S, et al. Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Autoimmunity Reviews. 2025. doi:10.1016/j.autrev.2025.103754

BibTeX
@article{Konen2025,
  author = {Konen, Franz Felix and Möhn, Nora and Witte, Torsten and Schefzyk, Matthias and Wiestler, Miriam and Lovric, Svjetlana and Hufendiek, Karsten and Jendretzky, Konstantin Fritz and Gingele, Stefan and Schwenkenbecher, Philipp and Sühs, Kurt-Wolfram and Friese, Manuel A and Klotz, Luisa and Pul, Refik and Pawlitzki, Marc and Hagin, David and Kleinschnitz, Christoph and Meuth, Sven G and Skripuletz, Thomas},
  title = {Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders},
  journal = {Autoimmunity Reviews},
  year = {2025},
  doi = {10.1016/j.autrev.2025.103754}
}
Kostenlos starten →